MANAGEMENT OF INTUSSUSCEPTION IN INFANTS AND CHILDREN: A SURVEY BASED ON 288 CONSECUTIVE CASES

PEDIATRICS ◽  
1972 ◽  
Vol 50 (4) ◽  
pp. 535-546
Author(s):  
Jan Gierup ◽  
Håkan Jorulf ◽  
Alexander Livaditis
Keyword(s):  
Intestinal Obstruction ◽  
Barium Enema ◽  
Reduction Rate ◽  
Accurate Diagnosis ◽  
Infants And Children ◽  
Consecutive Series ◽  
Duration Of Illness ◽  
Organic Lead ◽  
Enema Reduction ◽  
In Infants And Children

A consecutive series of 288 patients with intussusception is presented. It is shown that radiologic examination, including barium enema, is necessary to establish an early and accurate diagnosis. Barium enema reduction was the preferred therapeutic method. The reduction rate in relation to symptoms, duration of illness, type and site of intussusception, intestinal obstruction, and organic lead points is appraised. The reduction rate during the last decade was 87%.

scholarly journals Neonatal Intussusception: A Review

2018 ◽  
Vol 7 (1) ◽  
pp. 5 ◽  
Author(s):  
Vipul Prakash Bothara ◽  
Anand Pandey ◽  
Jiledar Rawat
Keyword(s):  
Intestinal Obstruction ◽  
Clinical Features ◽  
Premature Infants ◽  
Bowel Obstruction ◽  
Treatment Options ◽  
Infants And Children ◽  
Intestinal Lumen ◽  
Common Cause ◽  
Diagnostic Modalities ◽  
In Infants And Children

Intussusception is defined as a process in which a segment of bowel invaginates into the adjoining intestinal lumen, causing bowel obstruction. It is the most common cause of intestinal obstruction in infants and children between 6 months to 18 months of age. In neonates and premature infants, it accounts for only 3% of intestinal obstruction and 0.3% (0–2.7%) of all cases of intussusception Since neonatal intussusception is an uncommon entity, we conducted this review to examine its occurrence, clinical features, diagnostic modalities, and treatment options.

Intestinal Obstruction. I. Causes and Management in Infants and Children*

1955 ◽  
Vol 141 (6) ◽  
pp. 778-791
Author(s):  
Harwell Wilson ◽  
James D. Hardy ◽  
J. L. Farringer
Keyword(s):  
Intestinal Obstruction ◽  
Infants And Children ◽  
In Infants And Children

scholarly journals Are we doing better? Barium enema reduction of intussusception

2018 ◽  
Vol 100 (5) ◽  
pp. 388-391 ◽  
Author(s):  
L Pran ◽  
S Baijoo ◽  
B Rampersad
Keyword(s):  
Barium Enema ◽  
Reduction Rate ◽  
Operative Management ◽  
Paediatric Population ◽  
Chi Square ◽  
Abdominal Emergencies ◽  
Single Use ◽  
The Mean ◽  
Audit Cycle ◽  
Enema Reduction

Introduction Intussuception remains one of the most common surgical abdominal emergencies in the paediatric population. The aim of this study was first to re-evaluate our non-operative reduction rate of intussusception using multiple interval barium enemas and second to investigate or discuss an audit cycle, providing evidence and validating the modification of clinical practice. Materials and methods This five-year retrospective study performed at one of two institutions at which a paediatric surgical service is offered. Individuals included were all patients under 12-years of age who were diagnosed with intussusception. Factors considered to be influential in the reduction of the intussusception were collected. End points were defined as successful barium enema reduction or surgical intervention. Results were compared with similar research published in 2010. Results Overall prevalence was found to be 12 cases/year, with a sample size of 60 patients, the mean age at presentation of 13.6 months. Barium enema reduction was attempted in 56/60 patients, while 4/60 patients had operative management as a first intervention. Overall reduction rate was 66% (37/56), 78% occurring on first attempt and 22% on the second attempt. There was no evidence of intussusception in 3/19 patients who had operative management as a second intervention. Delayed interval barium enema reduction demonstrated an improved reduction rate of 66% compared with single-use barium enema reduction of 41% (chi square 0.02). Conclusion A significant benefit was achieved by performing delayed interval enema reduction, which contributed to a 61% increased reduction rate, the actual reduction rate approaches 71%. The audit cycle remains of paramount importance to ensure optimum patient care.

scholarly journals Current updates on HIV-related pulmonary disease in children: What do radiologists and clinicians need to know?

2015 ◽  
Vol 19 (2) ◽  
Author(s):  
Tracy Kilborn ◽  
Winnie C.W. Chu ◽  
K.M. Das ◽  
Bernard Laya ◽  
Edward Y. Lee
Keyword(s):  
Human Immunodeficiency Virus ◽  
Developing Countries ◽  
Hiv Infection ◽  
Accurate Diagnosis ◽  
Infants And Children ◽  
Imaging Findings ◽  
Current Management ◽  
Immunodeficiency Virus ◽  
Characteristic Imaging ◽  
In Infants And Children

Despite substantial advances in diagnosis and treatment, pulmonary human immunodeficiency virus (HIV) infection continues to be a major cause of morbidity and mortality in infants and children particularly those who live in developing countries. This article provides an up-to-date review on underlying etiology, often characteristic imaging findings and current management of pulmonary HIV infection in infants and children. Increased understanding of clinical and unique imaging findings of pulmonary HIV infection has a great potential for early and accurate diagnosis which, in turn, can eventually improve pediatric patient care.

scholarly journals Prospective randomized comparison of cefepime and cefotaxime for treatment of bacterial meningitis in infants and children.

1995 ◽  
Vol 39 (4) ◽  
pp. 937-940 ◽  
Author(s):  
X Sáez-Llorens ◽  
E Castaño ◽  
R García ◽  
C Báez ◽  
M Pérez ◽  
...  
Keyword(s):  
Cerebrospinal Fluid ◽  
Bacterial Meningitis ◽  
Clinical Status ◽  
Infants And Children ◽  
Treatment Groups ◽  
Treatment Regimens ◽  
Duration Of Illness ◽  
Neurologic Sequelae ◽  
History Of ◽  
In Infants And Children

Ninety infants and children were prospectively randomized to receive cefepime (n = 43) or cefotaxime (n = 47) for therapy of bacterial meningitis. The two treatment groups were comparable in terms of age, duration of illness before enrollment, history of seizures, clinical status on admission, and etiology. Six (7%) patients died--two treated with cefepime and four treated with cefotaxime. Clinical response, cerebrospinal fluid sterilization, development of complications, antibiotic toxicity, and hospital stay were similar for the two treatment regimens. Concentrations of cefepime in cerebrospinal fluid varied from 55 to 95 times greater than the maximal MIC required by the causative pathogens. Audiologic and/or neurologic sequelae were found in 16% of the cefepime-treated patients and 15% of the cefotaxime-treated patients examined 2 to 6 months after discharge. We conclude that cefepime is safe and therapeutically equivalent to cefotaxime for management of bacterial meningitis in infants and children.

Sign in / Sign up

Export Citation Format

Share Document